berberine has been researched along with Arterial Obstructive Diseases in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine was found to inhibit platelet aggregation, superoxide production via modulating AR, NOX, and glutathione reductase activities in high glucose (HG) treated platelets." | 1.51 | Berberine mitigates high glucose-potentiated platelet aggregation and apoptosis by modulating aldose reductase and NADPH oxidase activity. ( Girish, KS; Hemshekhar, M; Kemparaju, K; Paul, M, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paul, M | 1 |
| Hemshekhar, M | 1 |
| Kemparaju, K | 1 |
| Girish, KS | 1 |
1 other study available for berberine and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Berberine mitigates high glucose-potentiated platelet aggregation and apoptosis by modulating aldose reductase and NADPH oxidase activity.
Topics: Aldehyde Reductase; Antioxidants; Apoptosis; Arterial Occlusive Diseases; Berberine; Blood Platelets | 2019 |